期刊文献+

血液透析与血液透析滤过对糖尿病肾病尿毒症毒素MMS和PENT的清除观察 被引量:9

Clearance Effects of Hemodialysis and Hemodiafiltration on Uremic Toxins MMS and PENT in DKD-caused Uremia Patients
下载PDF
导出
摘要 目的观察糖尿病肾病尿毒症患者接受血液透析(HD)和血液透析滤过(HDF)治疗对中分子毒素(MMS)、晚期糖基化终产物戊糖素(PENT)的清除效果。方法选择符合入选标准的36例维持性血液透析DKD尿毒症患者,分为HD组(n=24)、HDF组(n=12),于单次治疗前后取血,测定血清尿素氮(BUN)、MMS、PENT,应用Daugirdas公式计算单次透析充分性(KT/V)。结果各组患者治疗后血清BUN水平均显著下降(P<0.01),KT/V均超过1.3,但各组间BUN下降率及KT/V差异无统计学意义。各组均能部分降低血清MMS、PENT水平,HDF对MMS、PENT的清除率优于常规HD清除(P<0.05)。结论血液透析滤过对糖尿病肾病尿毒症患者MMS、PENT清除明显优于常规血液透析。 Objective To investigate the effects of hemodialysis (HD)and hemodiafiltration(HDF) on pentosidine(PENT) and middle molecular substances (MMS )in diabetic kidney disease (DKD ) uremic patients.Methods 36 cases of DKD uremic hemodialysis pa-tients met the inclusion criteria were divided into 2 groups:HD group (n=24 ) ,HDF group (n=12 ).Before and after each conven-tional therapy ,blood was sampled for BUN ,MMS ,PENT.Each dialysis adequacy (KT/V) was calculated by the Daugirdas formu-la .Results The BUN in each group was significantly decreased ( P〈0.01) ,KT/V was more than 1.3 ,and there were no significant differences among the rates of BUN and KT/V descending among groups.Each group could partially reduce the levels of serum MMS , PENT ,but HDF did better than HD ( P〈0.05 ).Conclusions In terms of clearing MMS ,PENT for DKD-caused patients ,HDF is better than conventional HD.
出处 《心脑血管病防治》 2014年第3期186-188,191,共4页 CARDIO-CEREBROVASCULAR DISEASE PREVENTION AND TREATMENT
基金 广东省自然科学基金(S2013040016915 8151008901000056)
关键词 血液透析 血液透析滤过 中分子物质 戊糖素 Hemodialysis Hemodiafiltration Middle molecular substance Pentosidine
  • 相关文献

参考文献15

  • 1余学清,钱家麒.糖尿病终末期肾病血液透析和腹膜透析治疗[J].中国处方药,2009(4):60-61. 被引量:14
  • 2黎磊石,刘志红.中国肾脏病学[M].第一版.北京:人民军医出版社,2008:556-572.
  • 3Vanholder R, Meert N, Schepers E, et al. Uremic toxins: do we know e- nough to explain Uremic[J]? Blood Purif,2008,26( 1 ):77- 81.
  • 4Mostovaya IM, Blankestijn PJ, Bots ML, et al. Cinlcal evidence on hemodiafiltration: a systematic review and a meta-analysis[ J]. Semin Dial, 2014,27(2) : 119 - 127.
  • 5娄探奇,彭晖,陈珠江,石成钢,杨越雄,陈文峰.血液吸附对尿毒症中分子物质清除的临床观察[J].中山医科大学学报,2001,22(6):466-467. 被引量:8
  • 6王宏儒,鲍晓荣.不同血液净化方式对维持性血透患者尿毒素清除效果的观察[J].中国中西医结合肾病杂志,2013,14(3):215-218. 被引量:26
  • 7Vlassara FI, Brownlee M, Cerami A. Accumulation of diabetic rat periph- eral nerve myelin by macrophages increases with the presence of advanced glycosylation endproducts[ J]. J Exp Med, 1984,160( 1 ) : 197 - 207.
  • 8Meerwaldt R, Zeebregts CJ, Navis G, et al. Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialy- sis[J]. Am J Kidney Dis,2009,53(1) : 138 - 150.
  • 9Tessitore N, Lapolla A, Arico CN, et al. Hemodialysis techniques and ad- vanced glycation end products[J]. Contrib Nephrol,2001,131:33- 39.
  • 10Furuya R, Kumagai H, Odamaki M, et al. Impact of residual renal func- tion on plasma levels of advanced oxidation protein products and pentosidine in peritoneal dialysis patients[J]. Nephron Clin Pract,2009,112(4) : c255 - 261.

二级参考文献12

共引文献46

同被引文献65

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部